It is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that was initially developed to treat type 2 diabetes
The medication is prescribed by US-based clinicians after an online consultation process
GIP activation contributes to fat storage and energy expenditure
2, GLP-1 receptor agonists appear to exert cardiovascular benefit through mechanisms more closely related to metabolic and vascular risk modification
The present inventors when carried out the reaction of (3-31) amino acid fragment of Semaglutide having the amino acid sequence Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser- Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly with PGi-His(PG)-Aib-OH and further converted the obtained compound to Semaglutide surprisingly found that the said process efficiently controlled the formation of D-His, Des- His, Des-Aib, Di-Aib, Des-Aib-His impurities in the Semaglutide API which is highly advantageous on industrial scale especially for complex peptide molecules like Semaglutide
Your eligibility depends on your full medical history, current medications, and health goals
